OpenCapital
Beta
Calendar
Stocks
Metrics
Connect AI
/
Stocks
Portfolio
Sign In
Toggle navigation menu
Stocks
Medtronic
Balance Sheet Statement
Secured Borrowings Cash Right to Reclaim
Non-Current Liabilities
Secured Borrowings Cash Right to Reclaim
Export Chart
Analysis
Statement
Balance Sheet Statement
Section
Non-Current Liabilities
First reported
Q4 2015
Last reported
Q4 2025
Feb 24, 2026
Metric ID:
secured_borrowings_cash_right_to_reclaim
Historical Data
6 periods
Quarterly
Annual
TTM
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q2 '24
Q4 '25
Value
$12.00M
$0.00
$0.00
$1.00M
$0.00
$125.00M
QoQ Change
—
-100.0%
—
—
-100.0%
—
YoY Change
—
—
—
—
-100.0%
—
Range
$0.00 – $125.00M
CAGR
+551.9%
Avg YoY Growth
-100.0%
Median YoY Growth
-100.0%
Frequently Asked Questions
What is Medtronic's secured borrowings cash right to reclaim?
Medtronic (MDT) reported secured borrowings cash right to reclaim of $125.00M in Q1 2025.